A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial

Recruiting now

Conditions studied: Diabetic Foot Ulcer

In brief

This is a follow-up study to evaluate the safety for the subjects with ALLO-ASC-DFU treatment in phase 3 clinical trial (ALLO-ASC-DFU-302) for 24 months

Key facts

Study ID

NCT06141811

Run by

Anterogen Co., Ltd.

People needed

104

Starts

2023-04-25

Expected to finish

2026-03-31

Last updated by the study team

2024-12-13

Who can join

Age: 19 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who are treated with ALLO-ASC-DFU sheet or Vehicle sheet in phase 3 clinical trial of ALLO-ASC-DFU-302.
• Subjects who are able to give written informed consent prior to study start and to comply with the study requirements.

You may not qualify if…

• Subjects who are considered not suitable for the study by the principal investigator.

Where it is running

• Soonchunhyang University Hospital — Bucheon-si, Gyeonggi-do, South Korea (enrolling)
• Bucheon ST. Mary's Hospital — Bucheon-si, Gyeonggi-do, South Korea (enrolling)
• Asan Medical Center — Seoul, South Korea (enrolling)
• Borame Medical Center — Seoul, South Korea (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.